Annual FCF
-$15.40 M
+$15.09 M+49.48%
December 31, 2023
Summary
- As of February 24, 2025, BIOL annual free cash flow is -$15.40 million, with the most recent change of +$15.09 million (+49.48%) on December 31, 2023.
- During the last 3 years, BIOL annual FCF has fallen by -$2.51 million (-19.48%).
Performance
BIOL Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
-$4.51 M
-$3.75 M-492.90%
September 30, 2024
Summary
- As of February 24, 2025, BIOL quarterly free cash flow is -$4.51 million, with the most recent change of -$3.75 million (-492.90%) on September 30, 2024.
- Over the past year, BIOL quarterly FCF has dropped by -$1.74 million (-62.89%).
Performance
BIOL Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
-$13.68 M
-$1.74 M-14.59%
September 30, 2024
Summary
- As of February 24, 2025, BIOL TTM free cash flow is -$13.68 million, with the most recent change of -$1.74 million (-14.59%) on September 30, 2024.
- Over the past year, BIOL TTM FCF has increased by +$5.31 million (+27.96%).
Performance
BIOL TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
BIOL Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +49.5% | -62.9% | +28.0% |
| 3 y3 years | -19.5% | -62.9% | +28.0% |
| 5 y5 years | -4.7% | -62.9% | +28.0% |
BIOL Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +97.9% | +492.9% | +104.4% | +14.6% | +122.9% |
| 5 y | 5-year | +19.5% | +97.9% | +492.9% | +104.4% | +14.6% | +122.9% |
| alltime | all time | -354.2% | +97.9% | -182.1% | +126.2% | -325.8% | +122.9% |
BIOLASE Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.51 M(+492.9%) | -$13.68 M(+14.6%) |
| Jun 2024 | - | -$761.00 K(-87.2%) | -$11.94 M(-20.9%) |
| Mar 2024 | - | -$5.94 M(+140.6%) | -$15.10 M(-2.0%) |
| Dec 2023 | -$15.40 M(-49.5%) | -$2.47 M(-10.9%) | -$15.40 M(-18.9%) |
| Sep 2023 | - | -$2.77 M(-29.3%) | -$18.99 M(-25.4%) |
| Jun 2023 | - | -$3.92 M(-37.2%) | -$25.44 M(-10.4%) |
| Mar 2023 | - | -$6.25 M(+3.2%) | -$28.41 M(-6.8%) |
| Dec 2022 | -$30.49 M(+75.0%) | -$6.05 M(-34.4%) | -$30.49 M(+9.5%) |
| Sep 2022 | - | -$9.22 M(+34.0%) | -$27.85 M(+24.8%) |
| Jun 2022 | - | -$6.89 M(-17.3%) | -$22.31 M(+16.0%) |
| Mar 2022 | - | -$8.32 M(+143.8%) | -$19.23 M(+10.4%) |
| Dec 2021 | -$17.42 M(+35.1%) | -$3.42 M(-7.3%) | -$17.42 M(+13.3%) |
| Sep 2021 | - | -$3.68 M(-3.4%) | -$15.37 M(+11.4%) |
| Jun 2021 | - | -$3.81 M(-41.4%) | -$13.79 M(-9.6%) |
| Mar 2021 | - | -$6.51 M(+376.4%) | -$15.26 M(+18.3%) |
| Dec 2020 | -$12.89 M(-0.5%) | -$1.37 M(-35.1%) | -$12.89 M(-20.7%) |
| Sep 2020 | - | -$2.10 M(-60.1%) | -$16.27 M(+4.1%) |
| Jun 2020 | - | -$5.28 M(+27.4%) | -$15.62 M(+29.6%) |
| Mar 2020 | - | -$4.14 M(-12.6%) | -$12.05 M(-6.9%) |
| Dec 2019 | -$12.95 M(-11.9%) | -$4.74 M(+224.7%) | -$12.95 M(+6.0%) |
| Sep 2019 | - | -$1.46 M(-14.6%) | -$12.22 M(-6.0%) |
| Jun 2019 | - | -$1.71 M(-66.1%) | -$13.00 M(-12.6%) |
| Mar 2019 | - | -$5.04 M(+25.9%) | -$14.88 M(+1.2%) |
| Dec 2018 | -$14.71 M(-23.2%) | -$4.00 M(+78.4%) | -$14.71 M(-1.2%) |
| Sep 2018 | - | -$2.25 M(-37.5%) | -$14.88 M(-7.4%) |
| Jun 2018 | - | -$3.59 M(-26.2%) | -$16.07 M(-14.0%) |
| Mar 2018 | - | -$4.86 M(+16.4%) | -$18.69 M(-2.4%) |
| Dec 2017 | -$19.16 M(+59.5%) | -$4.18 M(+21.6%) | -$19.16 M(+3.7%) |
| Sep 2017 | - | -$3.44 M(-44.7%) | -$18.48 M(+10.2%) |
| Jun 2017 | - | -$6.21 M(+16.6%) | -$16.78 M(+37.2%) |
| Mar 2017 | - | -$5.33 M(+52.2%) | -$12.22 M(+1.8%) |
| Dec 2016 | -$12.01 M(-38.6%) | -$3.50 M(+102.3%) | -$12.01 M(+1.1%) |
| Sep 2016 | - | -$1.73 M(+4.2%) | -$11.88 M(-20.2%) |
| Jun 2016 | - | -$1.66 M(-67.5%) | -$14.88 M(-12.8%) |
| Mar 2016 | - | -$5.12 M(+51.9%) | -$17.06 M(-12.8%) |
| Dec 2015 | -$19.57 M(+19.4%) | -$3.37 M(-28.9%) | -$19.57 M(-11.6%) |
| Sep 2015 | - | -$4.74 M(+23.2%) | -$22.14 M(-10.9%) |
| Jun 2015 | - | -$3.84 M(-49.6%) | -$24.85 M(+17.5%) |
| Mar 2015 | - | -$7.63 M(+28.6%) | -$21.15 M(+28.9%) |
| Dec 2014 | -$16.40 M(+64.3%) | -$5.93 M(-20.3%) | -$16.40 M(+27.3%) |
| Sep 2014 | - | -$7.44 M(+5141.5%) | -$12.88 M(+70.2%) |
| Jun 2014 | - | -$142.00 K(-95.1%) | -$7.57 M(-23.5%) |
| Mar 2014 | - | -$2.88 M(+19.5%) | -$9.89 M(-0.9%) |
| Dec 2013 | -$9.98 M(+301.5%) | -$2.41 M(+13.2%) | -$9.98 M(+71.7%) |
| Sep 2013 | - | -$2.13 M(-13.5%) | -$5.81 M(+38.7%) |
| Jun 2013 | - | -$2.46 M(-17.0%) | -$4.19 M(-8.9%) |
| Mar 2013 | - | -$2.97 M(-269.2%) | -$4.60 M(+85.0%) |
| Dec 2012 | -$2.49 M(-81.9%) | $1.76 M(-443.6%) | -$2.49 M(-61.1%) |
| Sep 2012 | - | -$511.00 K(-82.2%) | -$6.39 M(-37.4%) |
| Jun 2012 | - | -$2.87 M(+234.3%) | -$10.22 M(+7.3%) |
| Mar 2012 | - | -$859.00 K(-60.1%) | -$9.53 M(-30.7%) |
| Dec 2011 | -$13.75 M(+239.5%) | -$2.15 M(-50.4%) | -$13.75 M(+15.9%) |
| Sep 2011 | - | -$4.34 M(+99.1%) | -$11.86 M(+40.1%) |
| Jun 2011 | - | -$2.18 M(-57.1%) | -$8.46 M(-12.3%) |
| Mar 2011 | - | -$5.08 M(+1839.7%) | -$9.65 M(+138.3%) |
| Dec 2010 | -$4.05 M(+34.1%) | -$262.00 K(-72.1%) | -$4.05 M(-13.7%) |
| Sep 2010 | - | -$940.00 K(-72.0%) | -$4.69 M(+31.9%) |
| Jun 2010 | - | -$3.36 M(-751.7%) | -$3.56 M(-377.6%) |
| Mar 2010 | - | $516.00 K(-157.1%) | $1.28 M(-142.4%) |
| Dec 2009 | -$3.02 M | -$904.00 K(-563.6%) | -$3.02 M(-57.8%) |
| Sep 2009 | - | $195.00 K(-86.8%) | -$7.16 M(-34.0%) |
| Jun 2009 | - | $1.47 M(-138.9%) | -$10.86 M(+9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2009 | - | -$3.79 M(-24.9%) | -$9.93 M(+80.5%) |
| Dec 2008 | -$5.50 M(+32.7%) | -$5.04 M(+44.0%) | -$5.50 M(+1228.7%) |
| Sep 2008 | - | -$3.50 M(-245.8%) | -$414.00 K(-116.5%) |
| Jun 2008 | - | $2.40 M(+274.7%) | $2.52 M(-285.7%) |
| Mar 2008 | - | $641.00 K(+1356.8%) | -$1.35 M(-67.3%) |
| Dec 2007 | -$4.14 M(+118.1%) | $44.00 K(-107.7%) | -$4.14 M(-40.8%) |
| Sep 2007 | - | -$571.00 K(-61.1%) | -$7.00 M(+38.5%) |
| Jun 2007 | - | -$1.47 M(-31.6%) | -$5.06 M(+216.6%) |
| Mar 2007 | - | -$2.15 M(-23.7%) | -$1.60 M(-15.9%) |
| Dec 2006 | -$1.90 M(-90.0%) | -$2.82 M(-304.5%) | -$1.90 M(-262.0%) |
| Sep 2006 | - | $1.38 M(-30.8%) | $1.17 M(-119.1%) |
| Jun 2006 | - | $1.99 M(-181.2%) | -$6.13 M(-45.1%) |
| Mar 2006 | - | -$2.45 M(-1053.7%) | -$11.16 M(-41.0%) |
| Dec 2005 | -$18.91 M(+530.1%) | $257.00 K(-104.3%) | -$18.91 M(-9.2%) |
| Sep 2005 | - | -$5.92 M(+94.7%) | -$20.82 M(+34.4%) |
| Jun 2005 | - | -$3.04 M(-70.2%) | -$15.50 M(+23.1%) |
| Mar 2005 | - | -$10.20 M(+517.7%) | -$12.59 M(+319.4%) |
| Dec 2004 | -$3.00 M(-149.5%) | -$1.65 M(+176.7%) | -$3.00 M(-172.4%) |
| Sep 2004 | - | -$597.00 K(+332.6%) | $4.15 M(+0.7%) |
| Jun 2004 | - | -$138.00 K(-77.6%) | $4.12 M(-20.6%) |
| Mar 2004 | - | -$615.00 K(-111.2%) | $5.19 M(-14.4%) |
| Dec 2003 | $6.06 M(<-9900.0%) | $5.50 M(-981.1%) | $6.06 M(+478.1%) |
| Sep 2003 | - | -$624.00 K(-167.2%) | $1.05 M(-48.2%) |
| Jun 2003 | - | $928.00 K(+261.1%) | $2.02 M(+70.8%) |
| Mar 2003 | - | $257.00 K(-47.2%) | $1.18 M(<-9900.0%) |
| Dec 2002 | -$1000.00(-99.9%) | $487.00 K(+39.1%) | -$1000.00(-99.7%) |
| Sep 2002 | - | $350.00 K(+288.9%) | -$368.00 K(-79.9%) |
| Jun 2002 | - | $90.00 K(-109.7%) | -$1.83 M(+32.4%) |
| Mar 2002 | - | -$928.00 K(-873.3%) | -$1.38 M(+12.3%) |
| Dec 2001 | -$1.23 M(-74.6%) | $120.00 K(-110.8%) | -$1.23 M(+68.1%) |
| Sep 2001 | - | -$1.11 M(-306.6%) | -$731.80 K(-58.9%) |
| Jun 2001 | - | $537.40 K(-169.2%) | -$1.78 M(-58.3%) |
| Mar 2001 | - | -$777.10 K(-225.7%) | -$4.27 M(-12.0%) |
| Dec 2000 | -$4.85 M(+146.6%) | $618.20 K(-128.6%) | -$4.85 M(-14.4%) |
| Sep 2000 | - | -$2.16 M(+10.7%) | -$5.66 M(+45.0%) |
| Jun 2000 | - | -$1.95 M(+43.5%) | -$3.90 M(+19.9%) |
| Mar 2000 | - | -$1.36 M(+588.5%) | -$3.26 M(+71.6%) |
| Dec 1999 | -$1.97 M(-61.5%) | -$197.30 K(-50.7%) | -$1.90 M(-24.1%) |
| Sep 1999 | - | -$400.00 K(-69.2%) | -$2.50 M(+56.3%) |
| Jun 1999 | - | -$1.30 M(<-9900.0%) | -$1.60 M(-54.3%) |
| Mar 1999 | - | $0.00(-100.0%) | -$3.50 M(-31.4%) |
| Dec 1998 | -$5.10 M(+24.4%) | -$800.00 K(-260.0%) | -$5.10 M(-13.6%) |
| Sep 1998 | - | $500.00 K(-115.6%) | -$5.90 M(-14.5%) |
| Jun 1998 | - | -$3.20 M(+100.0%) | -$6.90 M(+43.8%) |
| Mar 1998 | - | -$1.60 M(0.0%) | -$4.80 M(+17.1%) |
| Dec 1997 | -$4.10 M(+78.3%) | -$1.60 M(+220.0%) | -$4.10 M(+28.1%) |
| Sep 1997 | - | -$500.00 K(-54.5%) | -$3.20 M(0.0%) |
| Jun 1997 | - | -$1.10 M(+22.2%) | -$3.20 M(+23.1%) |
| Mar 1997 | - | -$900.00 K(+28.6%) | -$2.60 M(+18.2%) |
| Dec 1996 | -$2.30 M(+35.3%) | -$700.00 K(+40.0%) | -$2.20 M(+22.2%) |
| Sep 1996 | - | -$500.00 K(0.0%) | -$1.80 M(+5.9%) |
| Jun 1996 | - | -$500.00 K(0.0%) | -$1.70 M(+13.3%) |
| Mar 1996 | - | -$500.00 K(+66.7%) | -$1.50 M(-11.8%) |
| Dec 1995 | -$1.70 M(-37.0%) | -$300.00 K(-25.0%) | -$1.70 M(+21.4%) |
| Sep 1995 | - | -$400.00 K(+33.3%) | -$1.40 M(+40.0%) |
| Jun 1995 | - | -$300.00 K(-57.1%) | -$1.00 M(+42.9%) |
| Mar 1995 | - | -$700.00 K(-22.2%) | -$700.00 K(-88.5%) |
| Dec 1994 | -$2.70 M(-55.7%) | - | - |
| Dec 1993 | -$6.10 M(-1.6%) | -$900.00 K(-50.0%) | -$6.10 M(+17.3%) |
| Sep 1993 | - | -$1.80 M(+12.5%) | -$5.20 M(+52.9%) |
| Jun 1993 | - | -$1.60 M(-11.1%) | -$3.40 M(+88.9%) |
| Mar 1993 | - | -$1.80 M | -$1.80 M |
| Dec 1992 | -$6.20 M | - | - |
FAQ
- What is BIOLASE annual free cash flow?
- What is the all time high annual FCF for BIOLASE?
- What is BIOLASE annual FCF year-on-year change?
- What is BIOLASE quarterly free cash flow?
- What is the all time high quarterly FCF for BIOLASE?
- What is BIOLASE quarterly FCF year-on-year change?
- What is BIOLASE TTM free cash flow?
- What is the all time high TTM FCF for BIOLASE?
- What is BIOLASE TTM FCF year-on-year change?
What is BIOLASE annual free cash flow?
The current annual FCF of BIOL is -$15.40 M
What is the all time high annual FCF for BIOLASE?
BIOLASE all-time high annual free cash flow is $6.06 M
What is BIOLASE annual FCF year-on-year change?
Over the past year, BIOL annual free cash flow has changed by +$15.09 M (+49.48%)
What is BIOLASE quarterly free cash flow?
The current quarterly FCF of BIOL is -$4.51 M
What is the all time high quarterly FCF for BIOLASE?
BIOLASE all-time high quarterly free cash flow is $5.50 M
What is BIOLASE quarterly FCF year-on-year change?
Over the past year, BIOL quarterly free cash flow has changed by -$1.74 M (-62.89%)
What is BIOLASE TTM free cash flow?
The current TTM FCF of BIOL is -$13.68 M
What is the all time high TTM FCF for BIOLASE?
BIOLASE all-time high TTM free cash flow is $6.06 M
What is BIOLASE TTM FCF year-on-year change?
Over the past year, BIOL TTM free cash flow has changed by +$5.31 M (+27.96%)